HotSpot Therapeutics

HotSpot Therapeutics is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, pioneering allosteric drug discovery by targeting "natural hotspots" — the regulatory on/off switches on proteins. Its Smart Allostery platform combines AI-driven mining of large, diverse structural and biological data sets with a tailored pharmacology toolkit and bespoke medicinal chemistry to design first-in-class oral small molecules, and has been applied across E3 ligases, kinases and transcription factors. The company has raised roughly $190M across Series A, B and C financings and advanced its lead candidate HST-1011, an oral allosteric CBL-B inhibitor, into first-in-human dosing for cancer, alongside programs in autoimmune disease. HotSpot sells medicines and research collaborations, not software: it publishes no public developer program, API, SDK or machine-readable contract of any kind.

HotSpot Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Life Sciences.

HotSpot Therapeutics’ developer surface includes engineering blog and 6 more developer resources.

9.4/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-25 · rubric v0.14.0
0 APIs
CompanyBiotechnologyPharmaceuticalsDrug DiscoveryLife SciencesOncologyImmunologyArtificial IntelligenceHealth

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-25 · rubric v0.14.0
Composite quality — 9.4/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 3.6 / 17
Operational Transparency 0.3 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 2.6 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Delegated User Identity 0 / 6
Protected Resource Metadata 0 / 5
Registration Without a Human 0 / 6
Agentic Commerce Surface 0 / 5
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/hotspot-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Hotspot Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

Commercial 2

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: hotspot-therapeutics
name: HotSpot Therapeutics
description: 'HotSpot Therapeutics is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, pioneering
  allosteric drug discovery by targeting "natural hotspots" — the regulatory on/off switches on proteins. Its Smart Allostery
  platform combines AI-driven mining of large, diverse structural and biological data sets with a tailored pharmacology toolkit
  and bespoke medicinal chemistry to design first-in-class oral small molecules, and has been applied across E3 ligases, kinases
  and transcription factors. The company has raised roughly $190M across Series A, B and C financings and advanced its lead
  candidate HST-1011, an oral allosteric CBL-B inhibitor, into first-in-human dosing for cancer, alongside programs in autoimmune
  disease. HotSpot sells medicines and research collaborations, not software: it publishes no public developer program, API,
  SDK or machine-readable contract of any kind.'
image: https://avatars.githubusercontent.com/u/105356575?v=4
url: https://raw.githubusercontent.com/api-evangelist/hotspot-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-22'
modified: '2026-08-22'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Life Sciences
- Oncology
- Immunology
- Artificial Intelligence
- Health
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/hotspot-therapeutics-domain-security.yml
- type: Website
  url: https://www.hotspotthera.com/
- type: GitHubOrganization
  url: https://github.com/HotSpot-Therapeutics
- type: Blog
  url: https://www.hotspotthera.com/blog/
- type: PrivacyPolicy
  url: https://www.hotspotthera.com/privacy-policy/
- type: TermsOfService
  url: https://www.hotspotthera.com/terms-and-conditions/
- type: SecondaryMarketListing
  url: https://forgeglobal.com/hotspot-therapeutics_stock/
x-enrichment:
  date: '2026-08-22'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: HotSpot Therapeutics is a clinical-stage biopharmaceutical company whose product is an oral small-molecule drug
    pipeline (HST-1011, a CBL-B allosteric inhibitor), not software — its "Smart Allostery" AI platform is an internal discovery
    engine with no external interface, no api./docs./developer. host resolves in DNS, every /.well-known/ path 404s, and its
    only public GitHub repo is a fork of the third-party SETH bioinformatics tool.
  evidence:
  - url: https://www.hotspotthera.com/.well-known/api-catalog
    status: 404
  - url: https://www.hotspotthera.com/llms.txt
    status: 404
  - url: https://hotspotthera.com/.well-known/agent-card.json
    status: 404
  - url: https://api.github.com/orgs/HotSpot-Therapeutics/repos
    status: 200
  checked: '2026-08-22'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/hotspot-therapeutics"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/hotspot-therapeutics/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/hotspot-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.